Brought to you by 
Sanofi and Boehringer enter discussions to swap key businesses; Boehringer would pay €4.7bn cash; definitive agreement signed
15 Sep 2017
Executive Summary
Sanofi and Boehringer Ingelheim GMBH entered into exclusive discussions surrounding the swap of key businesses that could make Sanofi the number one consumer health care (CHC) firm in the world and help Boehringer become the second largest animal health company globally.
Deal Industry
- Pharmaceuticals
-
Pharmaceuticals
- OTC, Consumer
Deal Status
- Final
Deal Type
-
Acquisition
- Full Acquisition
- Payment Includes Cash
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Sanofi and Boehringer enter discussions to swap key businesses; Boehringer would pay €4.7bn cash; definitive agreement signed
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice